The Oxford-AstraZeneca vaccine, one of the world's leading COVID-19 vaccine candidates and Australia's best hope of a return to normality in 2021, could be approved by regulators as early as January.
Speaking to Health Minister Greg Hunt on Sunday, the global head of AstraZeneca confirmed the pharmaceutical giant would continue providing data to Australia with a view to gaining regulatory approval by the end of January.
Loading...
Natasha Boddy is Work & Careers reporter with The Australian Financial Review. She was previously a homepage editor and online producer. Connect with Natasha on Twitter. Email Natasha at natasha.boddy@afr.com
Ronald Mizen reports on politics, economics, business and the law, with a focus on corporate regulators, lobbyists and investigations from Parliament House, Canberra. Connect with Ronald on Twitter. Email Ronald at ronald.mizen@afr.com
